CONMED Corp — Director's Dealing 2017

Nov 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2017-11-03

Reporting Person: Berge Terence M (VP Corp. Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-03	Common Stock	M	2000	$16.46	Acquired	20250	Direct
2017-11-03	Common Stock	F	1129	$53.37	Disposed	19121	Direct
2017-11-03	Common Stock	M	2500	$26.69	Acquired	21621	Direct
2017-11-03	Common Stock	F	1713	$53.37	Disposed	19908	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-03	Sars (Stock Appreciation Rights)	$16.46	M	2000	Disposed	2019-06-01	Common Stock (2000)	Direct
2017-11-03	Sars (Stock Appreciation Rights)	$26.69	M	2500	Disposed	2018-06-01	Common Stock (2500)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F2: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.